Atrium Therapeutics Reports Second Quarter 2026 Financial Results

Go back to Atrium Therapeutics Reports Second Quarter 2026 Financial Results
PROSENSA HOLD (NASDAQ: RNA) Delayed: 8.42 --0 (-0%)
Previous Close $8.42    52 Week High $22.80 
Open $8.42    52 Week Low $4.12 
Day High $8.50    P/E N/A 
Day Low $8.21    EPS $0.00 
Volume 158,805       

PROSENSA HOLD (NASDAQ: RNA) Delayed: 8.42 --0 (-0%)
Previous Close $8.42    52 Week High $22.80 
Open $8.42    52 Week Low $4.12 
Day High $8.50    P/E N/A 
Day Low $8.21    EPS $0.00 
Volume 158,805